▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

1 Opportunity for Express Scripts Investors

By Jim Mueller, CFA and austin smith – Mar 26, 2013 at 1:34PM

NASDAQ: ESRX

Express Scripts Holding Company

Is there opportunity waiting for Express Scripts investors?

Express Scripts manages payments between pharmacy prescription plans and insurance companies, as well as helping select name-brand versus generic drugs. In this video, Fool analyst Jim Mueller explains how the expiration of several big pharma drugs could open up a big opportunity for Express Scripts.

About the Author

Jim learned how businesses are run while putting his Ph.D. in biochemistry to use at a small biotech company. He changed careers to work at the Fool, where he's improved his investing process and developed an appreciation for the long-term view.

TMFTortoise

Austin Smith owns shares of Pfizer. Jim Mueller has no position in any stocks mentioned. The Motley Fool recommends Express Scripts and UnitedHealth Group. The Motley Fool owns shares of Express Scripts. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services